Global  

Trusted News Discovery Since 2008
One News Page
One News Page > News Videos > Johnson & Johnson > Johnson & Johnson misses revenue estimates

Johnson & Johnson misses revenue estimates

Video Credit: Reuters Studio - Duration: 00:57s - Published
Johnson & Johnson misses revenue estimates

Johnson & Johnson misses revenue estimates

Johnson & Johnson on Wednesday posted a rare miss on quarterly revenue as sales of some of its major drugs fell short of Wall Street expectations.

Yahaira Jacquez reports.

0
shares
ShareTweetSavePostSend
 

Johnson & Johnson misses revenue estimates

Johnson & Johnson on Wednesday posted a rare miss on revenue, marking the first time in at least eight quarters that the healthcare giant fell short on sales expectations.

While sales did rise to $20.75 billion for the quarter, analysts were looking for $20.8 billion.

But intense competition for key drugs like Zytiga, a prostate cancer drug, coupled with pressure on prescription drug prices in the U.S, have weighed on J&J's pharmaceuticals unit... ...which makes up half of the company's overall sales and has powered much of the company's recent growth.

While revenue at the unit rose to $10.55 billion, is still missed Wall Street expectations.

Shares of the healthcare giant - which were trading at a record high - fell after it reported.




You Might Like


Tweets about this



Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2020 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.